Images
Contact
![](/sites/default/files/styles/medium_220px_width/public/2020-11/nahiaprueba_0.jpg?itok=lGhKXjfl)
The newspaper La Vanguardia devotes an article to the recently published work by the researcher Joan Massagué on breast cancer genetics and susceptibility to metastasis. Joan Massagué, chairman of the Cancer Biology and Genetics Program at the Memorial Sloan-Kettering Cancer Center – where the study was carried out – and adjunct director of IRB Barcelona, collaborates closely with the Oncology Program at IRB Barcelona, and especially with the MetLab, which focuses its efforts on the study of cancer metastasis.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).